Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer’s Agents Targeting BACE1 and PPARγ
In the last few decades, Alzheimer’s disease (AD) has emerged as a serious global problem, and it has been considered as the most common type of dementia. PPARγ and beta-secretase 1 (BACE1) are considered as potential targets for Alzheimer’s disease management. In the same time, sulfonylureas and su...
Saved in:
Main Authors: | Ning Li, Yan Wang, Wensheng Li, Haiyan Li, Liu Yang, Jun Wang, Hazem A. Mahdy, Ahmed B. M. Mehany, Dareen A. Jaiash, Eman Y. Santali, Ibrahim H. Eissa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Chemistry |
Online Access: | http://dx.doi.org/10.1155/2020/1631243 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
by: Timo Grimmer, et al.
Published: (2012-01-01) -
Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
by: Ajit A. Kulkarni, et al.
Published: (2012-01-01) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01) -
A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer
by: Xiao Yi Yang, et al.
Published: (2008-01-01) -
PPARγ in Inflammatory Bowel Disease
by: Vito Annese, et al.
Published: (2012-01-01)